Accelerated Medical Diagnostics Inc.
We will enhance the lives of cancer patients by providing proprietary assays for predicting which patients will respond to chemotherapy.
- Stage Prototype Ready
- Industry Medical Devices and Equipment
- Location Davis, CA, USA
- Currency USD
- Founded November 2012
- Employees 5
- Incorporation Type C-corp
- Website acceleratedmeddiagnostics.com
Company Summary
The goal of Accelerated Medical Diagnostics is to provide personalized therapy for cancer patients--specifically for those undergoing widely prescribed platinum-based chemotherapy. Our product, PlatinDx, is a diagnostic assay for predicting which patients will respond to platinum-based chemotherapy. This predictive technology does not require patient or tumor genotype information or culturing of tumor cells.
Team
-
George Cimino, PhDVP of Development
Former Founder and VP of Product Development at Cerus Inc.
-
Paul Henderson, PhDCEO
Faculty member of the UC Davis Department of Internal Medicine with over ten years of experience in applying mass spectrometry to cancer research
-
Chong-xian Pan, MD, PhDFounder
Practicing Clinical Oncologist and Associate Professor of Medicine at the UC Davis Department of Internal Medicine
-
William Hope, MBABusiness Development Consultant
MBA, University of Chicago Booth School of Business Emphasis in Strategic Management, Finance, and Entrepreneurship
-
Maike Zimmermann, PhDPostdoctoral Fellow
Recent PhD Graduate in Biochemistry Magna cum laude (very good) Department of Pharmacology University of Bielefeld (Germany), currently funded by the company to do research at UC Davis.
-
Neil Thompson, PhDAdvisor
Assistant Professor (MIT, Sloan School of Management) 2013 –
Entrepreneurship and Strategy
Advisors
-
DLA Piper/Fenwick and WestLawyerUnconfirmedBay Valley Accounting ProfessionalsAccountantUnconfirmed
Previous Investors
-
NIH/NCI SBIR ContractsUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.